View Item 

Show simple item record

Key Articles, Guidelines, and Consensus Papers Relative to the Treatment of Dyslipidemias—2005

dc.contributor.authorIto, Matthew K.en_US
dc.contributor.authorCheung, Rebecca J.en_US
dc.contributor.authorGupta, Eric K.en_US
dc.contributor.authorBirtcher, Kimberly K.en_US
dc.contributor.authorChong, Pang H.en_US
dc.contributor.authorBianco, Theresa M.en_US
dc.contributor.authorBleske, Barry E.en_US
dc.date.accessioned2012-03-16T15:53:49Z
dc.date.available2012-03-16T15:53:49Z
dc.date.issued2006-07en_US
dc.identifier.citationIto, Matthew K.; Cheung, Rebecca J.; Gupta, Eric K.; Birtcher, Kimberly K.; Chong, Pang H.; Bianco, Theresa M.; Bleske, Barry E. (2006). "Key Articles, Guidelines, and Consensus Papers Relative to the Treatment of Dyslipidemias—2005." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26(7). <http://hdl.handle.net/2027.42/90074>en_US
dc.identifier.issn0277-0008en_US
dc.identifier.issn1875-9114en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90074
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Ltden_US
dc.subject.otherHypertriglyceridemiaen_US
dc.subject.otherDyslipidemiaen_US
dc.subject.otherCholesterolen_US
dc.subject.otherGuidelinesen_US
dc.subject.otherHypercholesterolemiaen_US
dc.subject.otherCoronary Heart Diseaseen_US
dc.titleKey Articles, Guidelines, and Consensus Papers Relative to the Treatment of Dyslipidemias—2005en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCollege of Pharmacy, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherCollege of Pharmacy, Oregon State University, Portland Program at Oregon Health and Science University, Portland, Oregonen_US
dc.contributor.affiliationotherSchool of Pharmacy, Loma Linda University, Loma Linda, Californiaen_US
dc.contributor.affiliationotherSchool of Pharmacy, Western University, Pamona, Californiaen_US
dc.contributor.affiliationotherCollege of Pharmacy, University of Houston, Houston, Texasen_US
dc.contributor.affiliationotherDepartment of Pharmacy, John H. Stroger, Jr. Hospital, Chicago, Illinoisen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90074/1/phco.26.7.939.pdf
dc.identifier.doi10.1592/phco.26.7.939en_US
dc.identifier.sourcePharmacotherapy: The Journal of Human Pharmacology and Drug Therapyen_US
dc.identifier.citedreferenceExpert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106: 3143 – 421.en_US
dc.identifier.citedreferencePearson, T.A., Laurora, I., Chu, H., et al. The lipid treatment assessment project (L‐TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid‐lowering therapy and achieving low‐density lipoprotein cholesterol goals. Arch Intern Med 2000; 160: 459 – 67.en_US
dc.identifier.citedreferenceGenest, J.. Lipoprotein disorders and cardiovascular risk. J Inherit Metab Dis 2003; 26: 267 – 87.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
phco.26.7.939.pdf
Size:
347.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.